AllianceBernstein’s Vera Therapeutics VERA Stock Holding History

AllianceBernstein’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64M	Buy	1,591,043 +276,801	+21%	+$10.3M	0.02%	546
2026 Q1	$66.6M	Buy	1,314,242 +95,585	+8%	+$4.12M	0.02%	508
2025 Q4	$61.7M	Buy	1,218,657 +1,166,066	+2,217%	+$41.4M	0.02%	559
2025 Q3	$1.53M	Buy	52,591 +61	+0.1%	+$1.41K	﹤0.01%	2148
2025 Q2	$1.24M	Buy	52,530 +11,450	+28%	+$257K	﹤0.01%	2183
2025 Q1	$987K	Buy	41,080 +730	+2%	+$23.5K	﹤0.01%	2253
2024 Q4	$1.71M	Buy	40,350 +800	+2%	+$35.4K	﹤0.01%	2046
2024 Q3	$1.75M	Hold	39,550	–	–	﹤0.01%	2031
2024 Q2	$1.43M	Hold	39,550	–	–	﹤0.01%	2125
2024 Q1	$1.71M	Buy	39,550 +6,870	+21%	+$245K	﹤0.01%	2001
2023 Q4	$503K	Sell	32,680 -1,610	-5%	-$20.4K	﹤0.01%	2608
2023 Q3	$470K	Hold	34,290	–	–	﹤0.01%	2601
2023 Q2	$550K	Buy	+34,290	New	+$310K	﹤0.01%	2583

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein's VERA Position: Q2 2026 in Review

AllianceBernstein increased its Vera Therapeutics (VERA) stake by 21% in Q2 2026, buying an estimated $10.3M and bringing the position to 1,591,043 shares worth $64M. The position accounts for 0.02% of the portfolio, ranked #546.

AllianceBernstein first reported a position in VERA in Q2 2023 and has held it in 13 quarters since. The position peaked at $66.6M in Q1 2026. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

AllianceBernstein held 1,591,043 shares of Vera Therapeutics worth $64M as of Q2 2026.
AllianceBernstein bought 276,801 Vera Therapeutics shares in Q2 2026, an estimated $10.3M.
Vera Therapeutics made up 0.02% of AllianceBernstein's portfolio in Q2 2026, its #546 holding.
AllianceBernstein first reported a position in Vera Therapeutics in Q2 2023 and has held it in 13 quarters since.
AllianceBernstein's Vera Therapeutics position peaked at $66.6M in Q1 2026.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.